1,980
Views
3
CrossRef citations to date
0
Altmetric
Review

Hippo pathway inhibition by blocking the YAP/TAZ–TEAD interface: a patent review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 867-873 | Received 13 Jun 2018, Accepted 13 Nov 2018, Published online: 02 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yu Xu, Hongke Cai, Yuanfeng Xiong, Li Tang, Longjiang Li, Li Zhang, Yi Shen, Yongqiang Yang, Ling Lin & Jiayi Huang. (2023) YAP/TAZ axis was involved in the effects of metformin on breast cancer. Journal of Chemotherapy 35:7, pages 627-637.
Read now
Benjamin Zagiel, Patricia Melnyk & Philippe Cotelle. (2022) Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present). Expert Opinion on Therapeutic Patents 32:8, pages 899-912.
Read now
Laurence Booth, Andrew Poklepovic & Paul Dent. (2019) Not the comfy chair! Cancer drugs that act against multiple active sites. Expert Opinion on Therapeutic Targets 23:11, pages 893-901.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.